Picard Medical, Inc. PMI
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 6.30M | 5.48M | 4.95M | 4.77M | 4.47M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.30M | 5.48M | 4.95M | 4.77M | 4.47M |
| Cost of Revenue | 5.13M | 5.05M | 5.15M | 5.25M | 5.49M |
| Gross Profit | 1.17M | 429.00K | -204.00K | -479.00K | -1.02M |
| SG&A Expenses | 12.04M | 10.82M | 10.00M | 10.06M | 10.46M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 21.93M | 20.00M | 18.20M | 18.60M | 19.25M |
| Operating Income | -15.63M | -14.52M | -13.26M | -13.83M | -14.78M |
| Income Before Tax | -27.98M | -29.05M | -26.97M | -31.53M | -27.31M |
| Income Tax Expenses | 11.00K | 4.00K | 35.00K | 16.00K | 16.00K |
| Earnings from Continuing Operations | -27.99 | -29.06 | -27.00 | -31.55 | -27.33 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -27.99M | -29.06M | -27.00M | -31.55M | -27.33M |
| EBIT | -15.63M | -14.52M | -13.26M | -13.83M | -14.78M |
| EBITDA | -15.46M | -14.36M | -13.09M | -13.66M | -14.62M |
| EPS Basic | -21.00 | -60.35 | -95.74 | -153.82 | -188.28 |
| Normalized Basic EPS | -12.09 | -34.02 | -54.22 | -87.45 | -106.25 |
| EPS Diluted | -21.00 | -60.35 | -95.74 | -153.82 | -188.28 |
| Normalized Diluted EPS | -12.09 | -34.02 | -54.22 | -87.45 | -106.25 |
| Average Basic Shares Outstanding | 208.50M | 206.82M | 139.01M | 71.94M | 24.50M |
| Average Diluted Shares Outstanding | 208.50M | 206.82M | 139.01M | 71.94M | 24.50M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |